No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Tinea Corporis, also known as ringworm, is a fungal infection of the skin. It is caused by a variety of fungi, including dermatophytes, yeasts, and molds. Treatment of tinea corporis typically involves the use of antifungal drugs. These drugs can be administered topically, orally, or intravenously, depending on the severity of the infection. Common topical antifungal drugs used to treat tinea corporis include clotrimazole, miconazole, terbinafine, and ketoconazole. Oral antifungal drugs used to treat tinea corporis include fluconazole, itraconazole, and griseofulvin.
The Tinea Corporis Drug market is a segment of the larger Dermatological Drugs market. It is composed of a variety of antifungal drugs used to treat tinea corporis. These drugs are available in both generic and branded forms, and are sold through pharmacies, online retailers, and other outlets.
Some companies in the Tinea Corporis Drug market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. Show Less Read more
